{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:13:17Z","timestamp":1785787997895,"version":"3.56.0"},"reference-count":100,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T00:00:00Z","timestamp":1672012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"funded"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Discovery"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1080\/17460441.2023.2160439","type":"journal-article","created":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T06:06:01Z","timestamp":1671775561000},"page":"193-206","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["The Promising Therapeutic Potential of Oligonucleotides for Pulmonary Fibrotic Diseases"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4544-1825","authenticated-orcid":false,"given":"Divyani","family":"Paul","sequence":"first","affiliation":[{"name":"Eli Lilly and Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7008-5113","authenticated-orcid":false,"given":"Madelyn H","family":"Miller","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3231-6117","authenticated-orcid":false,"given":"Josh","family":"Born","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4406-8790","authenticated-orcid":false,"given":"Shayak","family":"Samaddar","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company","place":["Indianapolis, IN, US"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1713-3323","authenticated-orcid":false,"given":"Huanzhen","family":"Ni","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3742-589X","authenticated-orcid":false,"given":"Hugo","family":"Avila","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-7436","authenticated-orcid":false,"given":"Venkata R.","family":"Krishnamurthy","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Thirunavukkarasu","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,12,26]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30105-3"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00085-2020"},{"key":"e_1_3_7_5_1","unstructured":"Interstitial Lung Disease American Lung Association 2022. Available from: https:\/\/www.lung.org\/lung-health-diseases\/lung-disease-lookup\/interstitial-lung-disease"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080807"},{"key":"e_1_3_7_7_1","first-page":"68","volume-title":"Lung transplantation in idiopathic pulmonary fibrosis. Medical sciences","author":"Laporta Hernandez R","year":"2018","unstructured":"Laporta Hernandez R, Aguilar Perez M, L\u00e1zaro Carrasco MT, et al. Lung transplantation in idiopathic pulmonary fibrosis. Medical sciences. (Basel Switzerland): 2018 Aug 23;6(3):68."},{"issue":"65","key":"e_1_3_7_8_1","first-page":"A465","article-title":"Long-term tolerability of real-life use of antifibrotic agents (AFA) in Idiopathic Pulmonary Fibrosis (IPF)","volume":"58","author":"Strens D","year":"2021","unstructured":"Strens D, Bondue B, Dahlqvist C, et al. Long-term tolerability of real-life use of antifibrotic agents (AFA) in Idiopathic Pulmonary Fibrosis (IPF). Eur Respir J. 2021;58(suppl 65):A465.","journal-title":"Eur Respir J"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.05.054"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2022.115905"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.74"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12930"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1089\/ped.2010.0004"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12564"},{"key":"e_1_3_7_15_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.1998.275.6.L1192"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0864-2"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(13)70045-6"},{"key":"e_1_3_7_18_1","unstructured":"NAEPP: National Asthma Education and Prevention Program Tepotdamoa. Expert panel Report 3: guidelines for the diagnosis and management of asthma. Bethestda MD: National Heart Lung and Blood Institute (US).; 2017. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK7232\/."},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.2011.03929.x"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20092159"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.637948"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034975"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009996"},{"key":"e_1_3_7_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31222-9"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1513\/pats.200508-093DO"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60968-9"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30101-6"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ame2.12180"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00576-6"},{"issue":"5","key":"e_1_3_7_30_1","article-title":"Treatment of Pulmonary Disease of Cystic Fibrosis: a Comprehensive Review","volume":"10","author":"Giron Moreno RM","year":"2021","unstructured":"Giron Moreno RM, Garcia-Clemente M, Diab-Caceres L, et al. Treatment of Pulmonary Disease of Cystic Fibrosis: a Comprehensive Review. Antibiotics (Basel). 2021 Apr 23;10(5):486.","journal-title":"Antibiotics (Basel)"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2019.12.009"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2018.1501361"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2020.29029.cd"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21091249"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c05099"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.8b00650"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac037"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3948"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2005-0456OC"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3765"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm801294h"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jyp.2013.05.001"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aac5272"},{"key":"e_1_3_7_44_1","unstructured":"Ionis Pharmaceuticals I A Phase 1\/2a Study to Assess the Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic Fibrosis. 2018. https:\/\/ClinicalTrials.gov\/show\/NCT03647228"},{"key":"e_1_3_7_45_1","unstructured":"Sutharsan S Fischer R Gleiber W et al. Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of ION-827359 an Antisense Oligonucleotide Inhibitor of ENaC in Healthy Volunteers and Patients with Cystic Fibrosis: a Double-Blind Placebo-Controlled Dose-Escalation Phase 1\/2a Study. Healthy Volunteers and Patients with Cystic Fibrosis: A Double-Blind Placebo-Controlled Dose-Escalation Phase.1."},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-895X(24)05640-2"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.106.119214"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63478-5"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.1c06455"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10059-009-0134-8"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2021.06.003"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.070120"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0751-x"},{"key":"e_1_3_7_54_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A1043"},{"key":"e_1_3_7_55_1","unstructured":"4D-710 in Adult Patients With Cystic Fibrosis. https:\/\/ClinicalTrials.gov\/show\/NCT05248230."},{"key":"e_1_3_7_56_1","unstructured":"Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis. https:\/\/ClinicalTrials.gov\/show\/NCT03375047."},{"key":"e_1_3_7_57_1","unstructured":"CAP-1002 in Severe COVID-19 Disease. https:\/\/ClinicalTrials.gov\/show\/NCT04338347."},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34960-0"},{"key":"e_1_3_7_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2018.1440668"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2016.03.029"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1186\/rr58"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2011.12.014"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.07.024"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1089\/jamp.2011-0966"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1880"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.14356\/kona.2016014"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M312941200"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm1164"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.119974"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-8502(86)90035-2"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-3659(02)00363-2"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2007.11.009"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2020.03.016"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep22731"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2011.210"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2016.12.001"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9755-4"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2011.02.006"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2005.04.009"},{"key":"e_1_3_7_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.07.012"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61240-0"},{"key":"e_1_3_7_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201500120"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.762"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-010-0255-y"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S47681"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052408"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1021\/acschembio.0c00003"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2013.05.040"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2016.10.009"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12272-018-1069-4"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.10.030"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2019.03.028"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.12.004"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2019.03.052"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007504613351"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.03.041"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.2174\/156720105774370249"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.02.011"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep03325"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00166410"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.3109\/08958378.2014.907587"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/35078107"}],"container-title":["Expert Opinion on Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460441.2023.2160439","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:29:06Z","timestamp":1772771346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17460441.2023.2160439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,26]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.1080\/17460441.2023.2160439"],"URL":"https:\/\/doi.org\/10.1080\/17460441.2023.2160439","relation":{},"ISSN":["1746-0441","1746-045X"],"issn-type":[{"value":"1746-0441","type":"print"},{"value":"1746-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,26]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}